161 related articles for article (PubMed ID: 38332165)
21. Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
Zhou C; Wang Y; Ma L; Qian X; Yang C; Zeng M
Eur Radiol; 2022 Jan; 32(1):78-88. PubMed ID: 34279688
[TBL] [Abstract][Full Text] [Related]
22. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
23. Dual-phenotype hepatocellular carcinoma: correlation of MRI features with other primary hepatocellular carcinoma and differential diagnosis.
Zhang L; Chen J; Lai X; Zhang X; Xu J
Front Oncol; 2023; 13():1253873. PubMed ID: 38273849
[TBL] [Abstract][Full Text] [Related]
24. The added value of
Lv J; Yin H; Yu H; Shi H
Abdom Radiol (NY); 2023 Jul; 48(7):2331-2339. PubMed ID: 37119293
[TBL] [Abstract][Full Text] [Related]
25. MR features based on LI-RADS identify cytokeratin 19 status of hepatocellular carcinomas.
Hu XX; Wang WT; Yang L; Yang ZX; Liang HY; Ding Y; Ji Y; Zeng MS; Rao SX
Eur J Radiol; 2019 Apr; 113():7-14. PubMed ID: 30927962
[TBL] [Abstract][Full Text] [Related]
26. Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.
Yuan RH; Jeng YM; Hu RH; Lai PL; Lee PH; Cheng CC; Hsu HC
J Gastrointest Surg; 2011 Feb; 15(2):321-9. PubMed ID: 21061181
[TBL] [Abstract][Full Text] [Related]
27. Individual and joint influence of cytokeratin 19 and microvascular invasion on the prognosis of patients with hepatocellular carcinoma after hepatectomy.
Qin SD; Zhang J; Qi YP; Zhong JH; Xiang BD
World J Surg Oncol; 2022 Jun; 20(1):209. PubMed ID: 35725470
[TBL] [Abstract][Full Text] [Related]
28. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic study on combined hepatocellular carcinoma and cholangiocarcinoma: with emphasis on the intermediate cell morphology.
Park HS; Bae JS; Jang KY; Lee JH; Yu HC; Jung JH; Cho BH; Chung MJ; Moon WS
J Korean Med Sci; 2011 Aug; 26(8):1023-30. PubMed ID: 21860552
[TBL] [Abstract][Full Text] [Related]
30. [Impact of serum α-fetoprotein level on short-term recurrence after R0 resection in primary hepatocellular carcinoma].
Li SP; Wu LQ
Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):600-3. PubMed ID: 24256584
[TBL] [Abstract][Full Text] [Related]
31. Alpha-fetoprotein and
Yang Z; Luo FZ; Wang S; Lerut J; Zhuang L; Li QY; Xu X; Zheng SS
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):229-234. PubMed ID: 32303439
[TBL] [Abstract][Full Text] [Related]
32. Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization.
Nishihara Y; Aishima S; Kuroda Y; Iguchi T; Taguchi K; Asayama Y; Taketomi A; Kinukawa N; Honda H; Tsuneyoshi M
J Gastroenterol Hepatol; 2008 Dec; 23(12):1860-8. PubMed ID: 18823434
[TBL] [Abstract][Full Text] [Related]
33. The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.
Jiang T; Zhang XS; Pan F; Lyu SC; Wang J; Huang MX; He Q; Lang R
Medicine (Baltimore); 2021 Jul; 100(26):e26487. PubMed ID: 34190174
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers.
Witjes CD; ten Kate FJ; Verhoef C; de Man RA; IJzermans JN
J Clin Pathol; 2013 Aug; 66(8):687-91. PubMed ID: 23585667
[TBL] [Abstract][Full Text] [Related]
35. Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy-treated hepatocellular carcinoma.
Youn SY; Kim B; Kim DH; Choi HJ; Sung PS; Choi JI
Eur Radiol; 2022 Sep; 32(9):6270-6280. PubMed ID: 35348864
[TBL] [Abstract][Full Text] [Related]
36. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
37. Preoperative Diagnosis of Dual-Phenotype Hepatocellular Carcinoma Using Enhanced MRI Radiomics Models.
Wu Q; Yu YX; Zhang T; Zhu WJ; Fan YF; Wang XM; Hu CH
J Magn Reson Imaging; 2023 Apr; 57(4):1185-1196. PubMed ID: 36190656
[TBL] [Abstract][Full Text] [Related]
38. Association of CK19 expression with the efficacy of adjuvant transarterial chemoembolization after hepatic resection in hepatocellular carcinoma patients at high risk of recurrence.
Wu MS; Zhong JH; Chen K; Luo CP; Zhang J; Zhou YJ; Ma Y; Xiang BD
J Clin Transl Res; 2022 Feb; 8(1):71-79. PubMed ID: 35224238
[TBL] [Abstract][Full Text] [Related]
39. Peritumoral ductular reaction: a poor postoperative prognostic factor for hepatocellular carcinoma.
Xu M; Xie F; Qian G; Jing Y; Zhang S; Gao L; Zheng T; Wu M; Yang J; Wei L
BMC Cancer; 2014 Feb; 14():65. PubMed ID: 24495509
[TBL] [Abstract][Full Text] [Related]
40. CD34, PCNA and CK19 expressions in AFP- hepatocellular carcinoma.
Cui DJ; Wu Y; Wen DH
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5200-5205. PubMed ID: 30178842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]